iRhythm Technologies (IRTC) Misses Q2 EPS by 12c

iRhythm Technologies (NASDAQ: IRTC) reported Q2 EPS of ($0.51), $0.12 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $35.5 million versus the consensus estimate of $32.46 million.

GUIDANCE:

iRhythm Technologies sees FY2018 revenue of $138-141 million.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• AeroVironment restates quarterly financials, citing $89M goodwill error
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion